★ Sign in to follow
DB

DH Bray

CEO
US·SEC (Form 4)
Cannabis Science, Inc.Immunoclin Corp
Total declarations
25
Companies
2
▲ Purchases (2 ops.)
€73k
▼ Sales (10 ops.)
€1.4M

Latest filing published 18 Jun 2015 for CANNABIS SCIENCE, INC., €139k.

Insider track record

Disclosed buys
2
Disclosed sells
10
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

DH Bray: trading record in brief

Filings by DH Bray span 2 companies, the busiest being Cannabis Science, Inc. and Immunoclin Corp. In total, 25 filings cover trades dated from 21 October 2013 to 5 June 2015.

Both buying and selling appear: 2 purchases worth €73k, against 10 sales worth €1.4M. Netting one side against the other leaves €1.3M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 13 share grants. So far in 2015, the count stands at 1 purchase and 6 sales.

Most recently, on 18 June 2015, the filings show a share grant worth €139k in Cannabis Science, Inc. The last purchase on record was published on 18 June 2015, which is 4,161 days ago. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to DH Bray

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total
  • ◆
    DH Bray
    President, CEOExecutivesCannabis Science, Inc.
    190,000 USD0SEC
    5,000,000 shares@ US$0.038Common StockSEC:0001621170-15-000005:0
  • ▼
    DH Bray
    President, CEOExecutivesCannabis Science, Inc.
    63,800 USD0SEC
    2,000,000 shares@ US$0.0319Common StockSEC:0001621170-15-000005:1
  • ◆
    DH Bray
    President, CEOExecutivesCannabis Science, Inc.
    529,100 USD0SEC
    5,500,000 shares@ US$0.0962Common StockSEC:0001621170-15-000005:3
  • ◆
    DH Bray
    President, CEOExecutivesImmunoclin Corp
    4M USD0SEC
    1,000,000 shares@ US$4.00Common StockSEC:0001621170-15-000003:0
  • ▼
    DH Bray
    ExecutivesCannabis Science, Inc.
    79,553 USD0SEC
    1,260,750 shares@ US$0.0631Common StockSEC:0001621170-15-000001:0
  • ◆
    DH Bray
    President, C.E.O.ExecutivesCannabis Science, Inc.
    190,000 USD0SEC
    5,000,000 shares@ US$0.038Common StockSEC:0001621170-14-000003:0
  • ▼
    DH Bray
    President, C.E.O.ExecutivesCannabis Science, Inc.
    76,400 USD0SEC
    2,000,000 shares@ US$0.0382Common StockSEC:0001621170-14-000003:1
  • ▼
    DH Bray
    President, C.E.O.ExecutivesCannabis Science, Inc.
    411,500 USD0SEC
    5,000,000 shares@ US$0.0823Common StockSEC:0001621170-14-000003:2
  • ◆
    DH Bray
    President, C.E.O.ExecutivesCannabis Science, Inc.
    192,400 USD0SEC
    2,000,000 shares@ US$0.0962Common StockSEC:0001621170-14-000003:3
  • ▼
    DH Bray
    President, C.E.O.ExecutivesCannabis Science, Inc.
    261,600 USD0SEC
    2,000,000 shares@ US$0.1308Common StockSEC:0001621170-14-000003:4
  • ◆
    DH Bray
    President, C.E.O.ExecutivesCannabis Science, Inc.
    126,600 USD0SEC
    1,500,000 shares@ US$0.0844Common StockSEC:0001621170-14-000003:5
  • ▲
    DH Bray
    President, C.E.O.ExecutivesCannabis Science, Inc.
    50,000 USD0SEC
    200,000 shares@ US$0.25Common StockSEC:0001621170-14-000003:6
    Canonical exit: 12 Aug 2014 (T+90)
  • ▼
    DH Bray
    President, C.E.O.ExecutivesCannabis Science, Inc.
    83,700 USD0SEC
    1,500,000 shares@ US$0.0558Common StockSEC:0001621170-14-000003:7

13 of 13 declarations

Related entities

No related entities found.